No Images? Click here
Thursday, September 27, 2018, Biopôle, Lausanne
The race to innovate
& pathways to ROI
Perspectives from drug developers, investors and academia
Swiss Biotech Day is the leading biotechnology conference in Switzerland with an edition in spring and fall.
Join Swiss Biotech Day Fall, coinciding with EuropaBIO’s European Biotech Week, to meet senior executives from the Swiss biotech industry – entrepreneurs, investors, researchers, analysts, political decision makers and stakeholders.
The half-day program focuses on lessons to be learnt from the race to innovate, with perspectives from drug developers, investors and academia. Networking opportunities accompany plenary sessions.
Welcome & biotechnology report 2017
Dr. Michael Altorfer
CEO, Swiss Biotech Association
Juan Leston
EY, Office Managing Partner
Drug developer perspective
Dr. Ernest Loumaye
MD, PhD, CEO, ObsEva
Sascha Bucher
VP, Head of Global Transactions, Roivant Sciences
Dr. Nicolas Durand
CEO, Abionic
Investor perspective
Patrick Förg
Head Origination Primary Markets, SIX
Christian Fehr
Relationship Manager Primary Markets, SIX
Florent Gros
Partner, Novartis Venture Fund
Francesco de Rubertis
Founding Partner, Medicxi
Academic perspective & partnering
Dr. Alexandra Carrel
Cabinet Carrel, former General Counsel of Inserm Transfert
Gabrielle Gache
President, Swiss HealthCare Licensing Group
Aquatis Hotel - Biopôle
148 Route de Berne
1010 Lausanne
Metro stop “Vennes” on the M2 line
Parking available at P&R Vennes www.prvennes.ch
Thursday,
September 27, 2018
13:00-18:00
Organized by the Swiss Biotech Association & supported by the Swiss HealthCare Licensing Group
